Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma

Marina Pasca di Magliano(University of California, San Francisco), Andrew V. Biankin(Bankstown Lidcombe Hospital), Patrick W. Heiser(University of California, San Francisco), David A. Cano(University of California, San Francisco), Pedro J. A. Gutiérrez(University of California, San Francisco), Thérèse B. Deramaudt(University of Pennsylvania), Davendra Segara(St Vincent's Hospital), Amanda Dawson(Garvan Institute of Medical Research), James G. Kench(St Vincent's Hospital), Susan M. Henshall(St Vincent's Hospital), Robert L. Sutherland(Garvan Institute of Medical Research), Andrzej A. Dlugosz(University of Michigan–Ann Arbor), Anil K. Rustgi(University of Pennsylvania), Matthias Hebrok(University of California, San Francisco)
PLoS ONE
November 6, 2007
Cited by 230Open Access
Full Text

Abstract

Pancreatic ductal adenocarcinoma (PDA) is an extremely aggressive malignancy, which carries a dismal prognosis. Activating mutations of the Kras gene are common to the vast majority of human PDA. In addition, recent studies have demonstrated that embryonic signaling pathway such as Hedgehog and Notch are inappropriately upregulated in this disease. The role of another embryonic signaling pathway, namely the canonical Wnt cascade, is still controversial. Here, we use gene array analysis as a platform to demonstrate general activation of the canonical arm of the Wnt pathway in human PDA. Furthermore, we provide evidence for Wnt activation in mouse models of pancreatic cancer. Our results also indicate that Wnt signaling might be activated downstream of Hedgehog signaling, which is an early event in PDA evolution. Wnt inhibition blocked proliferation and induced apoptosis of cultured adenocarcinoma cells, thereby providing evidence to support the development of novel therapeutical strategies for Wnt inhibition in pancreatic adenocarcinoma.


Related Papers

No related papers found

Powered by citation graph analysis